未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity Rosenstock, Julio; Coskun, Tamer; Hartman, Mark L.; Lou, Jitong; Wu, Qiwei; Du, Yu; Gurbuz, Sirel; Mather, Kieren J.; Milicevic, Zvonko; Thomas, Melissa K. 分享 收藏
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial 三激素受体激动剂瑞他肽治疗代谢功能障碍相关的脂肪性肝病: 一项随机2a期试验 Sanyal, Arun J.; Kaplan, Lee M.; Frias, Juan P.; Brouwers, Bram; Wu, Qiwei; Thomas, Melissa K.; Harris, Charles; Schloot, Nanette C.; Du, Yu; Mather, Kieren J.; Haupt, Axel; Hartman, Mark L. 分享 收藏
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial 三激素受体激动剂瑞他肽治疗肥胖症-2期试验 Jastreboff, Ania M. M.; Kaplan, Lee M. M.; Frias, Juan P. P.; Wu, Qiwei; Du, Yu; Gurbuz, Sirel; Coskun, Tamer; Haupt, Axel; Milicevic, Zvonko; Hartman, Mark L. L. 分享 收藏
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Rosenstock, Julio; Frias, Juan; Jastreboff, Ania M.; Du, Yu; Lou, Jitong; Gurbuz, Sirel; Thomas, Melissa K.; Hartman, Mark L.; Haupt, Axel; Milicevic, Zvonko; Coskun, Tamer 分享 收藏
The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying 新型GIP、GLP-1和胰高血糖素受体激动剂瑞他肽延缓胃排空 Urva, Shweta; O'Farrell, Libbey; Du, Yu; Loh, Mei Teng; Hemmingway, Andrea; Qu, Hongchang; Alsina-Fernandez, Jorge; Haupt, Axel; Milicevic, Zvonko; Coskun, Tamer 分享 收藏
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist Benichou, Olivier; Coskun, Tamer; Gonciarz, Malgorzata D.; Garhyan, Parag; Adams, Andrew C.; Du, Yu; Dunbar, James D.; Martin, Jennifer A.; Mather, Kieren J.; Pickard, Richard T.; Reynolds, Vincent L.; Robins, Deborah A.; Zvada, Simbarashe P.; Emmerson, Paul J. 分享 收藏
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Urva, Shweta; Coskun, Tamer; Loh, Mei Teng; Du, Yu; Thomas, Melissa K.; Gurbuz, Sirel; Haupt, Axel; Benson, Charles T.; Hernandez-Illas, Martha; D'Alessio, David A.; Milicevic, Zvonko 分享 收藏
Joint modeling strategy for using electronic medical records data to build machine learning models: an example of intracerebral hemorrhage Tang, Jianxiang; Wang, Xiaoyu; Wan, Hongli; Lin, Chunying; Shao, Zilun; Chang, Yang; Wang, Hexuan; Wu, Yi; Zhang, Tao; Du, Yu 分享 收藏
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Coskun, Tamer; Urva, Shweta; Roell, William C.; Qu, Hongchang; Loghin, Corina; Moyers, Julie S.; O'Farrell, Libbey S.; Briere, Daniel A.; Sloop, Kyle W.; Thomas, Melissa K.; Pirro, Valentina; Wainscott, David B.; Willard, Francis S.; Abernathy, Matthew; Morford, LaRonda; Du, Yu; Benson, Charles; Gimeno, Ruth E.; Haupt, Axel; Milicevic, Zvonko 分享 收藏
LY3437943 (LY), a Novel Triple GIP/GLP-1/Glucagon Receptor Agonist, Provides Glucose Lowering and Weight Loss in Patients with T2DM after 12 Weeks of Treatment Urva, Shweta; Loh, Mei Teng; Coskun, Tamer; Du, Yu; Benson, Charles; Loghin, Corina; Haupt, Axel; Milicevic, Zvonko 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
